Topical medications | Ocular side effects | Systemic side effects | Contraindications | Drug interactions | Clinical notes | Cost for one container* | |
---|---|---|---|---|---|---|---|
Beta blockers | |||||||
Nonselective | |||||||
Timolol maleate (Timoptic, Timoptic-XE) | Burning/stinging; transient blurred vision (increased with gel); photophobia; conjunctivitis; blepharitis; punctate keratitis; contact dermatitis; eyelid erythema | Decreased heart rate/cardiac output; bronchospasm; hypotension; depression; decreased libido; impotence; worsened lipid profile; decreased stress response to hypoglycemia, surgery or anaphylaxis | Asthma; chronic obstructive pulmonary disease; congestive heart failure; sinus bradycardia; second- or third-degree atrioventricular block; hypersensitivity to beta blockers | Use cautiously with oral beta blockers, calcium channel blockers, quinidine, digitalis and catecholamine-depleting drugs (e.g., reserpine) | Lack of nocturnal effect; tachyphylaxis | Timoptic: 0.25 %, 5 mL, $16† Timoptic-XE: 0.25 %, 5 mL, $23 | |
Levobunolol (Betagan) | Increased relative to timolol | Same as timolol | Same as timolol, plus hypersensitivity to sulfite preservative | Same as timolol | Largest drop size | 0.25 %, 5 mL, $17† | |
Carteolol (Ocupress) | Same as timolol | Same as timolol | Same as timolol | Same as timolol | Some intrinsic sympathomimetic activity | 5 mL, $19 | |
Metipranolol (Optipranolol) | Has the most ocular side effects of the beta blockers in this class; anterior uveitis | Same as timolol | Same as timolol | Same as timolol | 5 mL, $13 | ||
Selective | |||||||
Betaxolol (Betoptic, Betoptic S) | Increased relative to timolol | Rare; fewer cardiopulmonary side effects than timolol | Sinus bradycardia; second- or third-degree atrioventricular block; overt congestive heart failure | Same as timolol, plus may antagonize adrenergic psychotropic drugs such as thioridazine (Mellaril) | Betoptic: 5 mL, $21 Betoptic S: 5 mL, $21 | ||
Miotics | |||||||
Pilocarpine (Isopto Carpine, Ocusert Pilo) | Burning; blurred vision; difficulty with night vision; miosis or accommodative spasm; lens opacity (rare); retinal detachment (rare); precipitation of closed-angle glaucoma (rare) | Sweating; salivation; urinary frequency; nausea; diarrhea; bronchospasm; biliary colic; mental status change; variable cardiovascular response | Hypersensitivity; poorly controlled asthma; acute iritis | May precipitate if administered with sodium sulfacetamide | Blurred vision increased with gel; miosis decreased with Ocusert Pilo; retinal detachment increased in patients with myopia; use with caution in patients with cataracts, hyperthyroidism, parkinsonism or urinary tract obstruction | Isopto Carpine: 0.25 %, 15 mL, $14† Ocusert Pilo: $40‡ | |
Carbonic anhydrase inhibitors | |||||||
Dorzolamide (Trusopt) | Burning; punctate keratitis; ocular allergies; increased ocular side effects relative to timolol | Bitter taste; headache; nausea; asthenia; kidney stones (rare) | Hypersensitivity to sulfonamides; eye injury or surgery | Not recommended for use with systemic carbonic anhydrase inhibitors; may accentuate side effects of salicylate therapy; may promote excretion of acidic drugs and inhibit renal excretion of basic drugs | Contact lenses must be removed; may be reinserted 15 minutes after installation of medication; not studied in patients in patients with hepatic or renal dysfunction | 2 %, 5 mL, $22 | |
Brinzolamide (Azopt) | Possibly decreased ocular side effects compared with dorzolamide; blepharitis; foreign-body sensation | Bitter taste; headache; rhinitis sensation | Hypersensitivity to sulfonamides | Same as dorzolamide | Same as dorzolamide | 1 %, 5 mL, $20 | |
Sympathomimetics | |||||||
Epinephrine-like Dipivefrin (Propine) | Burning; follicular conjunctivitis; macular edema in patients who are aphakic | Increased blood pressure; arrhythmias; tremor | Narrow-angle glaucoma | Use cautiously with cardiovascular or stimulant medications | Epinephrine prodrug; decreased ocular and systemic side effects relative to epinephrine; use cautiously in patients with cardiovascular disease | 0.1 %, 5 mL, $17† | |
Clonidine-like | |||||||
Brimonidine (Alphagan) | Conjunctival blanching; ocular allergy (less than with apraclonidine, more than with timolol) | Headache; drowsiness; fatigue; variable blood pressure response | Hypertensive crisis; therapy with monoamine oxidase inhibitors; hypersensitivity to clonidine (Catapres) | Use cautiously with antihypertensive medications and digitalis | Tachyphylaxis (less common); not studied in patients with hepatic or renal dysfunction | 0.2 %, 5 mL, $22 | |
Apraclonidine (Iopidine) | Allergic/local reaction; transient change in visual activity | Increased central nervous system effects change visual activity | Same as brimonidine | Same as brimonidine | Tachyphylaxis (common); short-term adjunctive agent, not first-line therapy | 0.5 %, 5 mL, $12 | |
Prostaglandin analogs | |||||||
Latanoprost (Xalatan) | Burning/stinging; iris pigmentation; punctate keratitis | Headache; symptoms of upper respiratory infection; chest pain (rare); myalgias (rare) | Hypersensitivity; narrow-angle closure; ocular infection or inflammation | May be precipitated by eyedrops that contain thimerosol (antiseptic) | Prodrug; diurnal decrease in intraocular pressure; not studied in patients with hepatic or renal dysfunction | 0.005 %, 2.5 mL, $42 |